News
Hosted on MSN18d
Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?GSK plc (NYSE:GSK) is advancing several promising ... 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap ...
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are creating turbulence within the Pharma sector.
In this article, we are going to take a look at where GSK ... the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap ...
could cause cancer were “admissible”, sparking a sell-off in GSK shares that wiped billions off its market cap. Now, the drugmaker and co-defendants, including Pfizer, Sanofi, and Boehringer ...
Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...
Its market cap is now £180bn, three times the size of GSK’s. Embarrassing! So is anything changing? Perhaps. The GSK share price is up 15% in the past three months. Full-year results ...
GSK (LSE:GSK) recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and ...
GSK market cap is currently £59.69B and has a P/E ratio of 23.26. Based on the recent corporate insider activity of 311 insiders, corporate insider sentiment is negative on the stock. This means ...
Its market cap is now £180bn, three times the size of GSK’s. Embarrassing! So is anything changing? Perhaps. The GSK share price is up 15% in the past three months. Full-year results, published on 5 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results